Literature DB >> 23733458

Virulence of vancomycin-resistant Enterococcus faecium according to linezolid resistance and clinical outbreak status.

Milena McLaughlin1, Michael Malczynski, Chao Qi, Grace Barajas, Jordan Radetski, Teresa Zembower, Marc H Scheetz.   

Abstract

Assessing clinical virulence differences between vancomycin-resistant Enterococcus faecium (VREF) strains resistant to linezolid (LRVRE) and linezolid-susceptible VRE (LSVRE) strains is difficult due to confounding patient variables. Galleria mellonella is a validated host interaction model allowing straightforward organism virulence assessment. The objective of this study was to assess the virulence of VREF in G. mellonella according to linezolid resistance and clinical outbreak status. A genetically related pair of VREF strains with and without genotypically confirmed linezolid resistance was selected for analysis. Additionally, six strains of LSVRE and two strains of LRVRE were selected according to epidemiologic outbreak status. Mortality of G. mellonella was assessed daily over a 5-day period and analyzed using Kaplan-Meier survival curves and log rank tests. Linezolid resistance did not have a significant effect on G. mellonella mortality in the genetically related pair (P = 0.93). There was no significant difference in mortality over time between strains (non-outbreak [i.e., no patient transmissions were recorded] [n = 2] versus outbreak [i.e., transmission occurred between 3 or more patients in a period of 30 days] [n = 6], P = 0.84; extensive transmission [i.e., the isolate was transmitted between at least 80 patients] [n = 2] versus limited transmission [i.e., the isolate was transmitted between fewer than 10 patients] [n = 4], P = 0.78). These results suggest that patients infected with LRVRE or outbreak strains of VREF are at no greater risk of poor outcomes mediated by organism virulence than those infected with LSVRE or non-outbreak strains.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23733458      PMCID: PMC3719778          DOI: 10.1128/AAC.00192-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia.

Authors:  Christopher W Woods; Adam M Bressler; John J LiPuma; Barbara D Alexander; Dennis A Clements; David J Weber; Christopher M Moore; L Barth Reller; Keith S Kaye
Journal:  Clin Infect Dis       Date:  2004-04-15       Impact factor: 9.079

2.  Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin.

Authors:  Issam I Raad; Hend A Hanna; Ray Y Hachem; Tanya Dvorak; Rebecca B Arbuckle; Gassan Chaiban; Louis B Rice
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 3.  Antimicrobial resistance to linezolid.

Authors:  Venkata G Meka; Howard S Gold
Journal:  Clin Infect Dis       Date:  2004-09-10       Impact factor: 9.079

4.  Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci.

Authors:  J Prystowsky; F Siddiqui; J Chosay; D L Shinabarger; J Millichap; L R Peterson; G A Noskin
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Evaluation of three disk tests for identification of enterococci, leuconostocs, and pediococci.

Authors:  R Facklam; N Pigott; R Franklin; J Elliott
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

7.  Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis.

Authors:  Eleftherios Mylonakis; Roberto Moreno; Joseph B El Khoury; Alexander Idnurm; Joseph Heitman; Stephen B Calderwood; Frederick M Ausubel; Andrew Diener
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

8.  Enterococcus faecium bacteremia: does vancomycin resistance make a difference?

Authors:  V Stosor; L R Peterson; M Postelnick; G A Noskin
Journal:  Arch Intern Med       Date:  1998-03-09

9.  Comparison of testing methods for detection of decreased linezolid susceptibility due to G2576T mutation of the 23S rRNA gene in Enterococcus faecium and Enterococcus faecalis.

Authors:  Chao Qi; Xiaotian Zheng; Arlene Obias; Marc H Scheetz; Michael Malczynski; John R Warren
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Temporal changes in pulsed-field gel electrophoresis banding in vancomycin-resistant Enterococcus faecium and implications for outbreak investigations.

Authors:  Milena McLaughlin; Michael Malczynski; Chao Qi; Jordan Radetski; Teresa Zembower; Marc H Scheetz
Journal:  Am J Infect Control       Date:  2012-10-24       Impact factor: 2.918

View more
  4 in total

1.  Pathogenicity of clinical Acinetobacter baumannii isolates in a Galleria mellonella host model according to bla(OXA-40) gene and epidemiological outbreak status.

Authors:  John S Esterly; Milena M McLaughlin; Michael Malczynski; Chao Qi; Teresa R Zembower; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

2.  Investigation of Linezolid Resistance in Staphylococci and Enterococci.

Authors:  Christopher D Doern; Jason Y Park; Michael Gallegos; Debbie Alspaugh; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2016-03-02       Impact factor: 5.948

3.  SURVEILLANCE FOR VANCOMYCIN RESISTANT ENTEROCOCCI IN A TERTIARY INSTITUTION IN SOUTH WESTERN NIGERIA.

Authors:  Agantem Emmanuel Ekuma; Oyin O Oduyebo; Akinwale Michael Efunshile; Brigitte Konig
Journal:  Afr J Infect Dis       Date:  2016-05-01

Review 4.  The Increasing Issue of Vancomycin-Resistant Enterococci and the Bacteriocin Solution.

Authors:  Ingvild S Reinseth; Kirill V Ovchinnikov; Hanne H Tønnesen; Harald Carlsen; Dzung B Diep
Journal:  Probiotics Antimicrob Proteins       Date:  2020-09       Impact factor: 4.609

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.